Real-time enrollment status for this refractory epilepsy clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:58 AM UTC
| NCT Number | NCT05493722 |
| Recruiting Status | Recruiting |
| Condition | Refractory Epilepsy |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Minnesota |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT05493722 is currently recruiting participants. This early_phase1 study for refractory epilepsy is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Minnesota. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05493722 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05493722 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.